These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28824547)

  • 1. The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis.
    Gründker C; Emons G
    Front Endocrinol (Lausanne); 2017; 8():187. PubMed ID: 28824547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of the gonadotropin-releasing hormone system in gynecological cancers.
    Gründker C; Günthert AR; Westphalen S; Emons G
    Eur J Endocrinol; 2002 Jan; 146(1):1-14. PubMed ID: 11751060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
    So WK; Cheng JC; Poon SL; Leung PC
    FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
    Eicke N; Günthert AR; Emons G; Gründker C
    Int J Oncol; 2006 Nov; 29(5):1223-9. PubMed ID: 17016655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH antagonists in the treatment of gynecological and breast cancers.
    Emons G; Gründker C; Günthert AR; Westphalen S; Kavanagh J; Verschraegen C
    Endocr Relat Cancer; 2003 Jun; 10(2):291-9. PubMed ID: 12790790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
    Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
    Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
    Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
    Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen.
    Günthert AR; Gründker C; Olota A; Läsche J; Eicke N; Emons G
    Eur J Endocrinol; 2005 Oct; 153(4):613-25. PubMed ID: 16189183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
    Schubert A; Hawighorst T; Emons G; Gründker C
    Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.
    Emons G; Müller V; Ortmann O; Schulz KD
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):199-206. PubMed ID: 9699874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-inhibitory actions of analogues of Luteinizing Hormone Releasing Hormone on tumor cells.
    Emons G; Ortmann O; Schulz KD; Schally AV
    Trends Endocrinol Metab; 1997 Nov; 8(9):355-62. PubMed ID: 18406825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
    Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
    Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium.
    Kang SK; Choi KC; Cheng KW; Nathwani PS; Auersperg N; Leung PC
    Endocrinology; 2000 Jan; 141(1):72-80. PubMed ID: 10614625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.